Dongwha Pharm.Co.Ltd Dividends and Buybacks
Dividend criteria checks 2/6
Dongwha Pharm.Co.Ltd is a dividend paying company with a current yield of 2.88% that is well covered by earnings. Next payment date is on 25th April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
2.9%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 17.7% |
| Next dividend pay date | 25 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩180.000 |
| Payout ratio | 65% |
Recent dividend and buyback updates
Recent updates
Dongwha Pharm.Co.Ltd's (KRX:000020) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 20
Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations
Mar 26Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?
Apr 28These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%
Feb 22Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?
Feb 07Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?
Jan 23Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?
Jan 08
Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days
Dec 24We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability
Dec 19Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?
Nov 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A000020 has been paying a dividend for less than 10 years.
Growing Dividend: A000020's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Dongwha Pharm.Co.Ltd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A000020) | 2.9% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A000020) (up to 3 years) | n/a |
Notable Dividend: A000020's dividend (2.88%) is higher than the bottom 25% of dividend payers in the KR market (1.17%).
High Dividend: A000020's dividend (2.88%) is low compared to the top 25% of dividend payers in the KR market (3.92%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (65%), A000020's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A000020 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 04:15 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dongwha Pharm.Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dodo Cheng | HSBC |